Form D — Alto Labs LLC
0002089151-25-000001 · filed Oct 2, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- Rule 506(b)
- Reported offering amount
- $400,000
- Reported amount sold
- $300,000
- Minimum investment
- $15,000
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Alto Labs LLC
- CIK
- 2089151
- Entity
- Limited Liability Company
- Jurisdiction
- TEXAS
- Year incorporated
- 2023
- Address
- 1801 S HILL STREET #200,
LOS ANGELES, California 90007 - Phone
- 310-709-1427
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Oliver Cohen · Executive OfficerNew York, New York Find on LinkedIn ↗
-
Matthew Makabeh · Executive OfficerLos Angeles, California Find on LinkedIn ↗
-
Adam Solomon · Executive OfficerLos Angeles, California Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗